FrancophonIA/ELRC3.0 huggingface dataset:
English: Consequently, as part of routine monitoring height, weight and BMI should be monitored at the start of treatment and every 3 months during the first year, then 6 monthly taking in to consideration clinical judgement with maintenance of a growth chart.
Slovenian: Zato je treba kot del rutinskega spremljanja spremljati telesno višino, telesno maso in ITM na začetku zdravljenja in prvo leto vsake 3 mesece, nato pa vsakih 6 mesecev, upoštevajoč klinično presojo pri vzdrževanju rastnih krivulj.
English: If guanfacine is combined with strong enzyme inducers, a retitration to increase the dose up to a maximum daily dose 7 mg (see section 4.2), may be considered if needed.
Slovenian: Če kombiniramo gvanfacin z močnimi encimskimi spodbujevalci, lahko pride v poštev ponovno titriranje za zvečanje odmerka na največji dnevni odmerek 7 mg (glejte poglavje 4.2).
English: Careful dose titration and monitoring is necessary at the start of treatment with Intuniv since clinical improvement and risks for several clinically significant adverse reactions (syncope, hypotension, bradycardia, somnolence and sedation) are dose- and exposure-related.
Slovenian: Na začetku zdravljenja z zdravilom Intuniv je potrebno skrbno titriranje in spremljanje odmerka, ker je klinično izboljšanje in tveganje več klinično pomembnih neželenih učinkov (sinkopa, hipotenzija, bradikardija, somnolenca in sedacija) povezano z odmerkom in izpostavljenostjo zdravilu.
English: When patients are taking Intuniv concomitantly with a CYP3A4 inducer, an increase in the dose of Intuniv within the recommended dose range is proposed (see section 4.2).
Slovenian: Kadar bolniki jemljejo zdravilo Intuniv sočasno s kakim spodbujevalcem CYP3A4, se priporoča zvečanje odmerka zdravila Intuniv znotraj priporočenega razpona odmerkov (glejte poglavje 4.2).
English: Respiratory, thoracic, and mediastinal disorders Asthma
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora astma občasni
English: • Summary of Product Characteristics (SmPC) and Package Leaflet
Slovenian: • povzetek o glavnih značilnostih zdravila (SPC) in navodilo za uporabo;
English: There was a substantial increase in the rate and extent of guanfacine exposure when administered with ketoconazole; the guanfacine peak plasma concentrations (Cmax) and exposure (AUC) increased 2- and 3-fold, respectively.
Slovenian: Pri dajanju skupaj s ketokonazolom sta se hitrost in obseg izpostavljenosti gvanfacinu znatno zvečala; največje koncentracije gvanfacina v plazmi (Cmax) in izpostavljenost gvanfacinu (AUC) so se zvečale za dvakrat oziroma trikrat.
English: • You may not notice an immediate effect upon starting treatment, some patients may notice an improvement after the first week but it could take longer.
Slovenian: Nekateri bolniki lahko opazijo izboljšanje po prvem tednu ali še pozneje.
English: • a serious withdrawal side effect of high blood pressure after suddenly stopping Intuniv; symptoms may include headaches, feeling confused, nervousness, agitation, and tremors (hypertensive encephalopathy).
Slovenian: • resen odtegnitveni neželeni učinek visokega krvnega tlaka po nenadni prekinitvi uporabe zdravila Intuniv; simptomi lahko vključujejo glavobol, zmedenost, živčnost, vznemirjenost in tresenje (hipertenzivna encefalopatija).
English: During dose titration, weekly monitoring for signs and symptoms of somnolence and sedation, hypotension and bradycardia should be performed.
Slovenian: Med titriranjem odmerka morate bolnika vsak teden spremljati glede znakov in simptomov somnolence in sedacije, hipotenzije in bradikardije.
English: Co-administration of Intuniv and valproic acid can result in increased concentrations of valproic acid.
Slovenian: Sočasno dajanje zdravila Intuniv in valproične kisline lahko zviša koncentracije valproične kisline.
English: Guanfacine is a substrate of CYP3A4 and CYP3A5, and exposure is affected by CYP3A4 and CYP3A5 inducers and inhibitors.
Slovenian: Gvanfacin je substrat CYP3A4 in CYP3A5, na izpostavljenost pa vplivajo spodbujevalci in zaviralci CYP3A4 in CYP3A5.
English: There are no or limited amount of data regarding effect on fertility from the use of guanfacine in humans.
Slovenian: Podatkov o vplivu jemanja gvanfacina na plodnost pri ljudeh ni oziroma so omejeni.
English: • fits or convulsions
Slovenian: • napadi ali krči,
English: Co-administration of Intuniv with moderate and strong CYP3A4/5 inhibitors elevates plasma guanfacine concentrations and increases the risk of adverse reactions such as hypotension, bradycardia, and sedation.
Slovenian: Sočasna uporaba zdravila Intuniv z zmernimi in močnimi zaviralci CYP3A4/5 zvišuje koncentracijo gvanfacina v plazmi in zvečuje tveganje neželenih učinkov, na primer hipotenzije, bradikardije in sedacije.
English: If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking this medicine.
Slovenian: Če kaj od zgoraj navedenega velja za vas (ali ste negotovi), se posvetujte z zdravnikom ali s farmacevtom, preden začnete jemati to zdravilo.
English: In addition 3 mg and 4 mg tablets include Indigo carmine aluminium lake E 132 Iron oxide yellow E 172
Slovenian: Poleg tega 3 mg in 4 mg tablete vsebujejo indigotin E132, rumeni železov oksid E172.
English: Study SPD503-307 was a 9-week, double-blind, randomised, placebo-controlled, dose-optimisation study with guanfacine (1-4 mg/day) conducted in children aged 6-12 years with ADHD and oppositional symptoms (n=217).
Slovenian: Študija SPD503-307 je bila 9-tedenska dvojno slepa, randomizirana, s placebom kontrolirana študija optimizacije odmerkov z gvanfacinom (1-4 mg/dan), ki so jo opravili pri otrocih, starih 6-12 let, z ADHD in uporniškimi simptomi (n=217).
English: Similar results for the efficacy of guanfacine in the treatment of ADHD were established in 2 randomised, double-blind, placebo-controlled, fixed-dose (range of 1-4 mg/day) monotherapy trials in paediatric patients (children and adolescents 6-17 years old inclusive).
Slovenian: Podobne rezultate za učinkovitost gvanfacina v zdravljenju ADHD so ugotovili v 2 randomiziranih, dvojno slepih, s placebom kontroliranih preskušanjih monoterapije s stalnim odmerkom (razpon 1-4 mg /dan) pri pediatričnih bolnikih (otroci in mladostniki, stari 6 do vključno 17 let).
English: The adverse reactions somnolence and sedation occurred predominantly at the start of treatment and may typically last for 2-3 weeks and longer in some cases.
Slovenian: Neželena učinka somnolenca in sedacija sta se pojavljala predvsem na začetku zdravljenja in lahko značilno trajata 2-3 tedne, v nekaterih primerih pa tudi dlje.
English: Intuniv can cause dizziness and somnolence.
Slovenian: Zdravilo Intuniv lahko povzroči omotico in somnolenco.
English: In phase II-III randomised double-blind monotherapy studies respective increases in QTc interval prolongation that exceeded change from baseline greater than 60 ms Fridericia-correction and Bazett-correction were 0 (0.0%) and 2 (0.3%) among placebo and 1 (0.1%) and 1 (0.1%) among Intuniv patients.
Slovenian: V randomiziranih dvojno slepih študijah monoterapije faze II-III se je interval QTc podaljšal od izhodišča za več kot 60 ms po Fridericijevem oziroma Bazettovem popravku pri 0 (0,0 %) oziroma 2 (0,3 %) bolnikih od tistih, ki so prejemali placebo, in pri 1 (0,1 %) oziroma 1 (0,1 %) bolniku od tistih, ki so jemali zdravilo Intuniv.
English: (statistical significance) over placebo on the family and school, and learning domains of the WFIRS-P score was not consistently established in this study.
Slovenian: Superiornost (statistična značilnost) v primerjavi s placebom glede družine in šole in domen učenja lestvice WFIRS-P v tej študiji ni bila zanesljivo dokazana.
English: CNS depressant medicinal products
Slovenian: Zdravila, ki deprimirajo CNS
English: • educational therapy
Slovenian: • edukacijsko terapijo,
English: In this study, no effect on d-amphetamine exposure was observed following combination of Intuniv and lisdexamfetamine dimesylate.
Slovenian: V tej študiji niso po kombinaciji zdravila Intuniv in lisdeksamfetaminijev dimesilata ugotovili nikakršnega vpliva na izpostavljenost d-amfetaminu.
English: The impact of renal impairment on the pharmacokinetics of guanfacine in paediatric patients (children and adolescents 6-17 years old) was not assessed.
Slovenian: Vpliva okvare jeter na farmakokinetiko gvanfacina pri pediatričnih bolnikih (otroci in mladostniki, stari 6-17 let) niso ocenjevali.
English: Guanfacine showed significantly greater improvement compared to placebo regardless of time (AM or PM) of administration (placebo-adjusted LS mean difference of -9.4 and -9.8 for AM and PM dosing, respectively, p<0.001).
Slovenian: Gvanfacin je pokazal značilno večje izboljšanje kot placebo ne glede na čas dajanja (dopoldne ali popoldne) (placebu prilagojena srednja razlika najmanjših kvadratov -9,4 in -9,8 za dopoldansko oziroma popoldansko odmerjanje, p<0,001).
English: • social therapy
Slovenian: • socialno terapijo.
English: If you need to take Intuniv for more than a year your doctor will monitor your response to treatment and your doctor may stop the medicine for a short time; this may happen during a school holiday.
Slovenian: Če boste morali jemati zdravilo Intuniv dlje od enega leta, bo vaš zdravnik spremljal vaš odziv na zdravljenje.
English: There was a significant decrease in the rate and extent of guanfacine exposure when co-administered with rifampin, a CYP3A4 inducer.
Slovenian: Hitrost in obseg izpostavljenosti gvanfacinu pri sočasnem dajanju z rifampinom, ki je spodbujevalec CYP3A4, sta se značilno zmanjšala.
English: Prior to prescribing, it is necessary to conduct a baseline evaluation to identify patients at increased risk of somnolence and sedation, hypotension and bradycardia, QT-prolongation arrhythmia and weight increase/risk of obesity.
Slovenian: Pred začetkom zdravljenja je treba opraviti izhodiščno ocenjevanje za prepoznavanje bolnikov, pri katerih je tveganje somnolence in sedacije, hipotenzije in bradikardije, aritmije s podaljšanim intervalom QT in zvečanjem telesne mase/debelosti zvečano.
English: Intuniv may cause somnolence and sedation predominantly at the start of treatment and could typically last for 2-3 weeks and longer in some cases.
Slovenian: Zdravilo Intuniv lahko povzroča somnolenco in sedacijo predvsem na začetku zdravljenja, kar navadno traja 2-3 tedne, v nekaterih primerih pa dlje.
English: In post-marketing experience, hypertensive encephalopathy has been very rarely reported upon abrupt discontinuation of Intuniv (see section 4.8).
Slovenian: V obdobju trženja so zelo redko poročali o pojavu hipertenzivne encefalopatije ob nenadni prekinitvi uporabe zdravila Intuniv (glejte poglavje 4.8).
English: In addition a 15-week, double-blind, randomised, placebo-controlled, dose-optimisation study (SPD503-312) conducted in adolescents aged 13-17 years (n=314) to confirm the efficacy, safety, and tolerability of guanfacine (1-7 mg/day) in the treatment of ADHD.
Slovenian: Poleg tega so izvedli 15-tedensko dvojno slepo, randomizirano študijo optimiziranja odmerka, kontrolirano s placebom (SPD503-312), pri mladostnikih, starih 13-17 let (n=314), da bi potrdili učinkovitost, varnost in prenašanje gvanfacina (1-7 mg/dan) pri zdravljenju ADHD.
English: In a maintenance of efficacy study, upon switching from guanfacine to placebo, 7/158 (4.4%) subjects experienced increases in blood pressure to values above 5 mmHg and also above the 95
Slovenian: V študiji vzdrževanja učinkovitosti je ob prehodu z gvanfacina na placebo pri 7/158 (4,4 %) posameznikih prišlo do zvišanja krvnega tlaka na vrednosti nad 5 mmHg in tudi nad 95. percentil za starost, spol in telesno višino (glejte poglavji 4.8 in 5.1).
English: Therefore, monitoring of height, weight and BMI should be done prior to initiation of therapy and then every 3 months for the first year, taking into consideration clinical judgement.
Slovenian: Zato moramo začeti s spremljanjem telesne višine, telesne mase in ITM pred uvedbo terapije in nato prvo leto vsake 3 mesece, pri čemer upoštevamo klinično presojo.
English: • feeling sleepy (somnolence)
Slovenian: • zaspanost (somnolenca),
English: Prior to initiation of treatment, patient's cardiovascular status including heart rate and blood pressure parameters, family history of sudden cardiac death /unexplained death, should be assessed to identify patients at increased risk of hypotension, bradycardia, and QT-prolongation/risk of arrhythmia.
Slovenian: Pred uvedbo zdravila moramo oceniti bolnikov kardiovaskularni status, vključno s parametri srčne frekvence in krvnega tlaka ter z rodbinsko anamnezo nenadne srčne smrti/ smrti iz neznanega vzroka, da bomo ugotovili, pri katerih bolnikih je zvečano tveganje hipotenzije, bradikardije in podaljšanja intervala QT/aritmije.
English: If any of the above apply to you or you are not sure, talk to your doctor or pharmacist before taking this medicine.
Slovenian: Če kaj od zgoraj navedenega velja za vas ali ste negotovi, se posvetujte z zdravnikom ali farmacevtom, preden začnete jemati to zdravilo.
English: If you have been told by your doctor that you cannot tolerate or digest some sugars, talk to your doctor or pharmacist before taking this medicine.
Slovenian: Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev, se pred uporabo tega zdravila posvetujte s svojim zdravnikom.
English: • your height and weight
Slovenian: • vašo telesno višino in telesno maso.
English: No adverse effects were observed in a fertility study in female rats at doses up to 22 times the maximum recommended human dose on a mg/m basis.
Slovenian: V študiji plodnosti na samicah podgan pri odmerkih, do 22-krat večjih od največjega priporočenega odmerka za človeka v mg/m2, niso ugotovili neželenih učinkov.
English: • The 3 mg and 4 mg tablets also contain indigo carmine E 132 and yellow iron oxide E 172 What Intuniv looks like and contents of the pack
Slovenian: • 3 mg in 4 mg tablete vsebujejo tudi indigotin E132 in rumeni železov oksid E172.
English: Atazanavir, efavirenz, etravirine, fosamprenavir, indinavir, nevirapine, ritonavir, saquinavir
Slovenian: Zdravila ki se uporabljajo za zdravljenje aprepitant siljenja na bruhanje in vrtoglavice atazanavir, efavirenz, etravirin, fosamprenavir, indinavir, nevirapin, ritonavir, sakvinavir okužbe s HIV
English: Three hundred and thirty-seven patients aged 6-17 years were evaluated in the pivotal Phase 3 Study SPD503-316, to assess safety and efficacy of once-daily dosing (children:1-4mg/day, adolescents: 1-7 mg/day).
Slovenian: V ključni študiji 3. faze SPD 503-316 so ovrednotili 337 bolnikov, starih 6-17 let, da bi ocenili varnost in učinkovitost odmerjanja enkrat na dan (otroci: 1-4 mg/dan, mladostniki: 1-7 mg/dan).
English: Intuniv causes a decrease in heart rate.
Slovenian: Zdravilo Intuniv znižuje srčno frekvenco.
English: In post-marketing experience, hypertensive encephalopathy has been very rarely reported upon abrupt discontinuation of Intuniv (see section 4.4).
Slovenian: V obdobju trženja so zelo redko poročali o pojavu hipertenzivne encefalopatije ob nenadni prekinitvi uporabe zdravila Intuniv (glejte poglavje 4.4).
English: Intuniv 1 mg prolonged-release tablets Intuniv 2 mg prolonged-release tablets Intuniv 3 mg prolonged-release tablets Intuniv 4 mg prolonged-release tablets
Slovenian: Intuniv 1 mg tablete s podaljšanim sproščanjem Intuniv 2 mg tablete s podaljšanim sproščanjem Intuniv 3 mg tablete s podaljšanim sproščanjem Intuniv 4 mg tablete s podaljšanim sproščanjem
English: Caution should be used when Intuniv is administered to patients taking ketoconazole and other moderate and strong CYP3A4/5 inhibitors, a decrease in the dose of Intuniv within the recommended dose range is proposed (see section 4.2).
Slovenian: Kadar dajemo zdravilo Intuniv bolnikom, ki jemljejo ketokonazol in druge zmerne ali močne zaviralce CYP3A4/5, je potrebna previdnost; priporočajo zmanjšanje odmerka zdravila Intuniv znotraj priporočenega razpona odmerkov (glejte poglavje 4.2).
English: 49.5-58.4 kg Max
Slovenian: 49,5-58,4 kg največji odmerek = 6 mg
English: How to take Intuniv
Slovenian: Kako jemati zdravilo Intuniv
English: Caution is advised when treating patients with Intuniv who have a history of hypotension, heart block, bradycardia, or cardiovascular disease, or who have a history of syncope or a condition that may predispose them to syncope, such as hypotension, orthostatic hypotension, bradycardia, or dehydration.
Slovenian: Pri zdravljenju bolnikov, ki imajo anamnezo hipotenzije, srčnega bloka, bradikardije ali kardiovaskularne bolezni, ali ki imajo anamnezo sinkope ali bolezni, zaradi katere bi se pri njih zvečala dovzetnost za sinkopo, na primer hipotenzijo, ortostatsko hipotenzijo, bradikardijo ali dehidracijo, z zdravilom Intuniv je priporočljiva previdnost.
English: • trouble breathing (asthma)
Slovenian: • oteženo dihanje (astma),
English: • fast heart beat (tachycardia)
Slovenian: • pospešen srčni utrip (tahikardija),
English: • difficulty to get or keep an erection (erectile dysfunction).
Slovenian: Neznana pogostost: pogostnosti iz razpoložljivih podatkov ni mogoče oceniti • težave pri doseganju ali ohranjanju erekcije (erektilna disfunkcija).
English: SHP503-401: In order to investigate the long term safety (especially effects on neurocognitive function) of Intuniv in Children and Adolescents Aged 6-17 Years with ADHD, the MAH should conduct and submit the results of a comparative safety study according to an agreed protocol.
Slovenian: SHP503-401: MAH bo moral izvesti primerjalno študijo varnosti v skladu z dogovorjenim protokolom in predložiti rezultate, da bo raziskal dolgoročno varnost (posebno učinke na nevrokognitivno funkcijo) zdravila Intuniv pri otrocih in mladostnikih z ADHD, starih 6-17 let.
English: 34-41.4 kg Max
Slovenian: 34-41,4 kg največji odmerek = 4 mg
English: CYP3A4 and CYP3A5 inhibitors
Slovenian: Zaviralci CYP3A4 in CYP3A5
English: Rare: may affect up to 1 in 1,000 people
Slovenian: Redki: lahko se pojavijo pri največ 1 od 1.000 bolnikov
English: • If you stop taking this medicine your blood pressure and heart rate may increase (see section 4
Slovenian: • Če boste prenehali jemati to zdravilo, se vam bosta mogoče zvečala krvni tlak in srčni utrip
English: Swallow the tablet whole.
Slovenian: Tableto pogoltnite célo.
English: Each 3 mg tablet contains 37.81 mg of lactose (as monohydrate).
Slovenian: Ena 3 mg tableta vsebuje 37,81 mg laktoze (v obliki monohidrata).
English: Some of these side effects are more likely to occur at the start of treatment and may disappear as you continue with your treatment, if you experience any of these side effects contact your doctor straight away.
Slovenian: Nekateri od teh neželenih učinkov se bodo verjetno pojavili na začetku zdravljenja in lahko med nadaljevanjem zdravljenja izginejo.
English: 7 prolonged-release tablets 28 prolonged-release tablets 84 prolonged-release tablets
Slovenian: 7 tablet s podaljšanim sproščanjem 28 tablet s podaljšanim sproščanjem 84 tablet s podaljšanim sproščanjem
English: 41.5-49.4 kg Max
Slovenian: 41,5-49,4 kg največji odmerek = 5 mg
English: See section 4.2 for further dosing recommendations
Slovenian: Za nadaljnja priporočila glede odmerjanja glejte poglavje 4.2.
English: Intuniv contains lactose.
Slovenian: Zdravilo Intuniv vsebuje laktozo.
English: Change from baseline (SD)
Slovenian: Spremem ba od izhodišča (SD)
English: Adverse Drug Reactions Reported with Intuniv System/Organ Class
Slovenian: Neželeni učinki, o katerih poročajo pri zdravilu Intuniv Organski sistemi
English: • diarrhoea, abdominal discomfort or constipation
Slovenian: • driska, neugodje v trebuhu ali zaprtost,
English: 28 prolonged-release tablets 84 prolonged-release tablets
Slovenian: 28 tablet s podaljšanim sproščanjem 84 tablet s podaljšanim sproščanjem
English: Other CYP3A4/5 inhibitors may have a comparable effect, see table 3 for a list of examples of moderate and strong CYP3A4/5 inhibitors, this list is not definitive.
Slovenian: Glejte preglednico 3 za seznam primerov zmernih in močnih zaviralcev CYP3A4/5; ta seznam ni dokončen.
English: 7 prolonged-release tablets 28 prolonged-release tablets
Slovenian: 7 tablet s podaljšanim sproščanjem 28 tablet s podaljšanim sproščanjem
English: o somnolence and sedation o hypotension o bradycardia
Slovenian: • znakov in simptomov: o somnolence in sedacije, o hipotenzije, o bradikardije,
English: Blood pressure and heart rate increase upon discontinuation Blood pressure and pulse may increase following discontinuation of Intuniv.
Slovenian: Zvišanje krvnega tlaka in pospešitev srčnega utripa ob prekinitvi zdravljenja Po prekinitvi zdravljenja z zdravilom Intuniv se lahko krvni tlak zviša in srčni utrip pospeši.
English: Blood pressure and heart rate increase upon discontinuation of Intuniv Blood pressure and pulse may increase following discontinuation of Intuniv.
Slovenian: Zvišanje krvnega tlaka in pospešitev srčnega utripa ob prekinitvi zdravljenja z zdravilom Intuniv Po prekinitvi zdravljenja z zdravilom Intuniv se lahko krvni tlak zviša in srčni utrip pospeši.
English: Intuniv contains the active substance guanfacine.
Slovenian: Zdravilo Intuniv vsebuje zdravilno učinkovino gvanfacin.
English: What Intuniv contains
Slovenian: Kaj vsebuje zdravilo Intuniv
English: Patients treated with CYP3A4 and CYP3A5 inhibitors/inducers CYP3A4/5 inhibitors have been shown to have a significant effect on the pharmacokinetics of guanfacine when co-administered.
Slovenian: Dokazali so, da zaviralci CYP3A4/5 signifikantno vplivajo na farmakokinetiko gvanfacina, če jih dajemo skupaj z njim.
English: Intuniv 1 mg tablet
Slovenian: Intuniv 1 mg tableta
English: Each 4 mg tablet contains 50.42 mg of lactose (as monohydrate).
Slovenian: Ena 4 mg tableta vsebuje 50,42 mg laktoze (v obliki monohidrata).
English: CYP3A4 inducers
Slovenian: Spodbujevalci CYP3A4
English: Intuniv 2 mg tablet EU/1/15/1040/003-005
Slovenian: Intuniv 2 mg tableta EU/1/15/1040/003-005
English: • feeling dizzy when standing up (postural dizziness)
Slovenian: • omedlevica pri vstajanju (posturalna omotica),
English: Intuniv 4 mg tablet EU/1/15/1040/008-009
Slovenian: Intuniv 4 mg tableta EU/1/15/1040/008-009
English: • pale skin colour (pallor)
Slovenian: • bledica kože,
English: Intuniv 3 mg tablet EU/1/15/1040/006-007
Slovenian: Intuniv 3 mg tableta EU/1/15/1040/006-007
English: Intuniv 1 mg pack sizes: 7 or 28 tablets.
Slovenian: Velikosti pakiranja zdravila Intuniv 1 mg: 7 ali 28 tablet.
English: Intuniv 4 mg tablet
Slovenian: Intuniv 4 mg tableta
English: Intuniv 2 mg tablet
Slovenian: Intuniv 2 mg tableta
English: Intuniv 2 mg pack sizes: 7, 28 or 84 tablets.
Slovenian: Velikosti pakiranja zdravila Intuniv 2 mg: 7, 28 or 84 tablet.
English: Talk to your doctor or pharmacist before taking this medicine if:
Slovenian: Pred začetkom jemanja zdravila Intuniv se posvetujte z zdravnikom ali s farmacevtom, če:
English: • indigestion (dyspepsia)
Slovenian: • prebavne motnje (dispepsija),
English: • feeling tired (fatigue)
Slovenian: • utrujenost,
English: Other CYP3A4 inducers may have a comparable effect, see table 3 for a list of examples of CYP3A4/5 inducers, this list is not definitive.
Slovenian: Glejte preglednico 3 za seznam primerov spodbujevalcev CYP3A4/5; ta seznam ni dokončen.
English: Intuniv 1 mg tablet EU/1/15/1040/001-002
Slovenian: Intuniv 1 mg tableta EU/1/15/1040/001-002
English: Each 2 mg tablet contains 44.82 mg of lactose (as monohydrate).
Slovenian: Ena 2 mg tableta vsebuje 44,82 mg laktoze (v obliki monohidrata).
English: What Intuniv is used for
Slovenian: Za kaj zdravilo Intuniv uporabljamo
English: Each 1 mg tablet contains 22.41 mg of lactose (as monohydrate).
Slovenian: Ena 1 mg tableta vsebuje 22,41 mg laktoze (v obliki monohidrata).
English: What Intuniv is
Slovenian: Kaj je zdravilo Intuniv
English: 7.14mm round, white to off-white tablets debossed with ‘1MG' on one side and ‘503' on the other side.
Slovenian: Okrogle, bele do belkaste tablete, 7,14 mm v premeru, z vtisnjenim napisom ‘1MG' na eni strani in ‘503' na drugi strani.